BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 1687364)

  • 1. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes.
    Woodward RM; Panicker MM; Miledi R
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4708-12. PubMed ID: 1350095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of SCH 39166 and SCH 23390 to 5-HT1C receptors in porcine choroid plexus.
    Taylor LA; Tedford CE; McQuade RD
    Life Sci; 1991; 49(20):1505-11. PubMed ID: 1943454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.
    Terry P; Katz JL
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):328-33. PubMed ID: 7862841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus.
    Hoyer D; Karpf A
    Eur J Pharmacol; 1988 May; 150(1-2):181-4. PubMed ID: 3402537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK; Ross GM; Bajwa SB; Mishra RK
    Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
    Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
    J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 synthesis-modulating receptors are present in the striatum of the guinea pig.
    Johnson EA; Tsai CE; Lucci J; Harrison-Shahan Y; Azzaro AJ
    Neuropharmacology; 1992 Jan; 31(1):95-101. PubMed ID: 1347405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture.
    Bryson SE; Drew GM; Hall AS; Ball SG; Balmforth AJ
    Eur J Pharmacol; 1992 Jan; 225(1):1-5. PubMed ID: 1347268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR; Lubbers L; van Oosten RV; Andringa G
    Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors.
    Ohlstein EH; Berkowitz BA
    Eur J Pharmacol; 1985 Jan; 108(2):205-8. PubMed ID: 3884345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats.
    Katz JL; Kopajtic TA; Terry P
    Behav Pharmacol; 2006 Jun; 17(4):303-9. PubMed ID: 16914948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
    Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
    Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
    Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.